• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use?2005 年乳腺 X 光检查率的下降是否与激素疗法使用的下降有关?
Cancer. 2011 Dec 15;117(24):5450-60. doi: 10.1002/cncr.26218. Epub 2011 Aug 22.
2
Update on mammography trends: comparisons of rates in 2000, 2005, and 2008.乳腺摄影趋势更新:2000 年、2005 年和 2008 年的发生率比较。
Cancer. 2011 May 15;117(10):2209-18. doi: 10.1002/cncr.25679. Epub 2010 Nov 30.
3
Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.当前、曾经和从未使用激素治疗的女性中,乳房 X 光筛查的使用情况可能无法解释最近乳腺癌发病率的下降。
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):720-7. doi: 10.1158/1055-9965.EPI-11-1115. Epub 2012 Feb 1.
4
An Exploration of Changes in the Measurement of Mammography in the National Health Interview Survey.国家健康访谈调查中乳房 X 光摄影测量变化的探索。
Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1611-1618. doi: 10.1158/1055-9965.EPI-17-0213. Epub 2017 Sep 8.
5
Screening mammography intervals among postmenopausal hormone therapy users and nonusers.绝经后激素治疗使用者和非使用者的筛查性乳房 X 光检查间隔。
Cancer Causes Control. 2010 Jan;21(1):147-52. doi: 10.1007/s10552-009-9444-6. Epub 2009 Oct 21.
6
Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.加利福尼亚州马林县高发人群中激素治疗利用和乳腺癌发病率的近期趋势。
BMC Public Health. 2010 Apr 30;10:228. doi: 10.1186/1471-2458-10-228.
7
Reported drop in mammography : is this cause for concern?乳腺钼靶检查报告的下降:这值得担忧吗?
Cancer. 2007 Jun 15;109(12):2405-9. doi: 10.1002/cncr.22723.
8
Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women.最近接受过乳房 X 光筛查的女性中,自费进行乳房 X 光筛查的比例。
J Womens Health (Larchmt). 2019 Jul;28(7):910-918. doi: 10.1089/jwh.2018.6973. Epub 2018 Sep 28.
9
Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations.2009 年美国预防服务工作组建议发布后,乳腺 X 光筛查率的趋势。
Cancer. 2013 Jul 15;119(14):2518-23. doi: 10.1002/cncr.28105. Epub 2013 Apr 19.
10
Breast cancer incidence and hormone replacement therapy in Canada.加拿大的乳腺癌发病率与激素替代疗法。
J Natl Cancer Inst. 2010 Oct 6;102(19):1489-95. doi: 10.1093/jnci/djq345. Epub 2010 Sep 23.

引用本文的文献

1
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.绝经激素治疗的类型和时机与乳腺癌风险:全球流行病学证据的个体参与者荟萃分析。
Lancet. 2019 Sep 28;394(10204):1159-1168. doi: 10.1016/S0140-6736(19)31709-X. Epub 2019 Aug 29.
2
Determinants of Cancer Screening Disparities Among Asian Americans: A Systematic Review of Public Health Surveys.亚裔美国人癌症筛查差异的决定因素:公共卫生调查的系统评价
J Cancer Educ. 2018 Aug;33(4):757-768. doi: 10.1007/s13187-017-1211-x.
3
The cost of cancer-related physician services to Medicare.医疗保险中与癌症相关的医生服务费用。
Yale J Biol Med. 2015 Jun 1;88(2):107-14. eCollection 2015 Jun.
4
Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors.在公共卫生研究中使用大规模调查的机遇与挑战:癌症筛查行为评估的比较
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):3-14. doi: 10.1158/1055-9965.EPI-14-0568. Epub 2014 Oct 9.
5
The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women?“欢迎加入 Medicare”就诊:女性错失癌症筛查的机会?
J Womens Health (Larchmt). 2013 Jan;22(1):19-25. doi: 10.1089/jwh.2012.3777. Epub 2012 Nov 12.

本文引用的文献

1
Update on mammography trends: comparisons of rates in 2000, 2005, and 2008.乳腺摄影趋势更新:2000 年、2005 年和 2008 年的发生率比较。
Cancer. 2011 May 15;117(10):2209-18. doi: 10.1002/cncr.25679. Epub 2010 Nov 30.
2
Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.与激素治疗使用率下降相关的浸润性乳腺癌和导管原位癌发生率的变化。
J Clin Oncol. 2010 Dec 10;28(35):5140-6. doi: 10.1200/JCO.2010.29.5121. Epub 2010 Nov 8.
3
Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders.干预措施以提高医疗保健提供者对乳腺癌、宫颈癌和结直肠癌筛查的建议和实施率:提供者提醒的系统评价。
Am J Prev Med. 2010 Jan;38(1):110-7. doi: 10.1016/j.amepre.2009.09.031.
4
Characteristics associated with mammography screening among both Hispanic and non-Hispanic white women. Hispanic 和非 Hispanic 白种女性进行乳房 X 光筛查的相关特征。
J Womens Health (Larchmt). 2009 Oct;18(10):1585-894. doi: 10.1089/jwh.2008.1009.
5
Bias associated with self-report of prior screening mammography.与既往乳腺筛查钼靶检查自我报告相关的偏倚。
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1699-705. doi: 10.1158/1055-9965.EPI-09-0020.
6
The social determinants of cancer: a challenge for transdisciplinary science.癌症的社会决定因素:跨学科科学面临的一项挑战。
Am J Prev Med. 2008 Aug;35(2 Suppl):S141-50. doi: 10.1016/j.amepre.2008.05.006.
7
Falling behind: Americans' access to medical care deteriorates, 2003-2007.落后:2003 - 2007年美国人获得医疗服务的情况恶化。
Track Rep. 2008 Jun(19):1-5.
8
Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives.通过对医疗服务提供者评估与反馈以及医疗服务提供者激励措施的系统评价,来增加医疗服务提供者对乳腺癌、宫颈癌和结直肠癌筛查的推荐及实施的干预措施。
Am J Prev Med. 2008 Jul;35(1 Suppl):S67-74. doi: 10.1016/j.amepre.2008.04.008.
9
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.回复:筛查乳腺钼靶人群中浸润性乳腺癌的下降及绝经后激素治疗的使用情况
J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. doi: 10.1093/jnci/djn079. Epub 2008 Apr 8.
10
Accuracy of self-reported cancer-screening histories: a meta-analysis.自我报告的癌症筛查史的准确性:一项荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):748-57. doi: 10.1158/1055-9965.EPI-07-2629. Epub 2008 Apr 1.

2005 年乳腺 X 光检查率的下降是否与激素疗法使用的下降有关?

Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use?

机构信息

Division of Cancer Control and Population Sciences, National Institute, Bethesda, Maryland 20852-7344, USA.

出版信息

Cancer. 2011 Dec 15;117(24):5450-60. doi: 10.1002/cncr.26218. Epub 2011 Aug 22.

DOI:10.1002/cncr.26218
PMID:21861265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3223554/
Abstract

BACKGROUND

In 2005, mammography rates in the United States dropped nationally for the first time among age-eligible women. An increased risk of breast cancer related to hormone therapy (HT) use reported in 2002 led to a dramatic drop in its use by 2005. Because current users of HT also tend to have higher mammography rates, the authors examined whether concurrent drops in HT and mammography use were associated.

METHODS

Multivariate logistic regression was used to test for an interaction between HT use and survey year, controlling for a range of measurable factors in data from the 2000 and 2005 National Health Interview Surveys (NHIS).

RESULTS

Women ages 50 to 64 years were more likely to report a recent mammogram if they also reported more education, a usual source of care, private health insurance, any race except non-Hispanic Asian, talking with an obstetrician/gynecologist or other physician in the past 12 months, or were currently taking HT. Women aged ≥ 65 years were more likely to report a recent mammogram if they also reported younger age (ages 65-74 years), more education, a usual source of care, having Medicare Part B or other supplemental Medicare insurance, excellent health, any race except non-Hispanic Asian, talking with an obstetrician/gynecologist or other physician in the past 12 months, or were currently taking HT.

CONCLUSIONS

The change in HT use was associated with the drop in mammography use for women ages 50 to 64 years but not for women aged ≥ 65 years. NHIS data explained 70% to 80% of the change in mammography use.

摘要

背景

2005 年,美国符合条件的女性中,乳腺 X 光检查率首次出现全国性下降。2002 年报告的激素治疗(HT)使用与乳腺癌风险增加相关,导致 2005 年 HT 的使用量急剧下降。由于当前使用 HT 的女性也往往有更高的乳腺 X 光检查率,作者研究了 HT 和乳腺 X 光检查使用量同时下降是否存在关联。

方法

使用多变量逻辑回归检验 HT 使用与调查年份之间的交互作用,控制了 2000 年和 2005 年全国健康访谈调查(NHIS)数据中一系列可衡量因素。

结果

50 至 64 岁的女性如果报告了更多的教育程度、常规医疗来源、私人医疗保险、除非西班牙裔亚裔以外的任何种族、过去 12 个月内与妇产科医生或其他医生交谈过,或者正在服用 HT,则更有可能报告最近进行过乳腺 X 光检查。65 岁及以上的女性如果报告了更年轻的年龄(65-74 岁)、更多的教育程度、常规医疗来源、拥有 Medicare Part B 或其他补充 Medicare 保险、健康状况良好、除非西班牙裔亚裔以外的任何种族、过去 12 个月内与妇产科医生或其他医生交谈过,或者正在服用 HT,则更有可能报告最近进行过乳腺 X 光检查。

结论

HT 使用的变化与 50 至 64 岁女性的乳腺 X 光检查使用率下降有关,但与 65 岁及以上女性无关。NHIS 数据解释了乳腺 X 光检查使用率变化的 70%至 80%。